Frontlight ResearchEarly access
Trial site
National Institute Of Endocrinology C.I. Parhon
- 9running trials
- 2closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Cushing's syndrome2 trials
- High blood pressure2 trials
- Obesity2 trials
- Type 2 diabetes2 trials
- Childhood cancers1 trial
- Graves' disease1 trial
- Thyroid cancer1 trial
- Turner syndrome1 trial
- Phase
- Phase 36 trials
- Phase 23 trials
- Phase 42 trials
- Status
- Active, not recruiting4 trials
- Recruiting3 trials
- Completed2 trials
- Not yet recruiting2 trials
- Lead sponsor
- Pfizer2 trials
- Spruce Biosciences2 trials
- argenx1 trial
- Ascendis Pharma Bone Diseases A/S1 trial
- Ascendis Pharma Endocrinology Division A/S1 trial
- and 4 more
Running trials
Recruiting
Osilodrostat in Patients With Hypertension Caused by Hypercortisolaemia Due to Cushing's Syndrome
Not yet recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Cushing's syndrome1 recruiting
- Graves' disease1 recruiting
- High blood pressure1 recruiting
- Turner syndrome1 recruiting
Closed trials
Site data: EU CTIS (euclinicaltrials.eu)Updated 17 Nov 2026